Erythrocyte binding properties of streptococcal lipoteichoic acids

Streptococcal lipoteichoic acids (LTAs) are known to interact with animal cell membranes, but the specific mechanisms and receptors involved remain unclear. Prior research has shown that LTAs from gram-positive bacteria can bind to various cell surfaces, but the extent of binding to erythrocytes has not been fully characterized. Established knowledge includes the role of LTAs in bacterial adhesion and immune recognition. However, the binding affinities and site densities on different erythrocyte types have not been systematically compared. This paper addresses the gap in understanding how LTA from specific streptococcal species interacts with human and sheep erythrocytes. The study provides new data on binding kinetics and site numbers, which were previously unquantified for these cell types. The authors also investigate whether binding is reversible and what factors might inhibit it. This work contributes to the broader field by offering precise measurements of LTA-erythrocyte interactions.

The study aimed to determine the binding properties of Streptococcus pyogenes and S. faecalis LTAs to human and sheep erythrocytes. Researchers sought to quantify binding affinities and site densities on different erythrocyte types. The goal was to assess whether binding is reversible and to identify potential inhibitors. The authors also investigated whether LTA from other gram-positive species could interfere with binding. Another objective was to determine if specific cell surface treatments affect LTA binding. The study also examined the role of ester-linked lipids in membrane binding. The researchers wanted to clarify the mechanisms underlying LTA-erythrocyte interactions. This work provides a detailed analysis of LTA binding characteristics that were previously unknown.

The researchers used radiolabeled LTA ([(3)H]LTA) from S. pyogenes and S. faecalis to study binding to erythrocytes. They measured binding kinetics and calculated dissociation constants for different erythrocyte types. The number of binding sites per cell was determined using binding assays. Reversibility was tested by displacing bound [(3)H]LTA with unlabeled LTA. The study also tested the inhibitory effects of LTA from other gram-positive species. Researchers evaluated various compounds as potential inhibitors of LTA binding. Erythrocytes were treated with trypsin or neuraminidase to assess their effects on binding. Deacylated [(3)H]LTA was esterified with stearoyl chloride to test its binding ability.

The dissociation constants for [(3)H]LTA binding to sheep and adult human erythrocytes were 1.6 muM and 4.5 muM, respectively. Human cord blood erythrocytes had a dissociation constant of 31 muM, about 10-fold higher. The number of binding sites per sheep erythrocyte was 7.2 x 10(6), and for human erythrocytes, 29 x 10(6). Binding was reversible, with more than 50% of [(3)H]LTA displaced by a 50-fold excess of unlabeled LTA. LTA from other gram-positive species inhibited [(3)H]LTA binding regardless of source. Among tested inhibitors, only albumin and gangliosides Gm(2) and Gm(3) significantly reduced binding. Trypsin or neuraminidase treatment did not affect LTA binding. Deacylated [(3)H]LTA lost binding ability, but esterification with stearoyl chloride restored it.

The authors conclude that LTA from S. pyogenes and S. faecalis bind to erythrocytes with measurable affinities and site densities. They propose that binding is reversible and that heterologous LTAs can inhibit binding. The study suggests that albumin and gangliosides may act as receptor analogues or inhibitors. The findings indicate that ester-linked lipids are necessary for LTA membrane binding. The authors state that trypsin or neuraminidase treatment does not affect LTA binding. The results imply that LTA binding is not dependent on sialic acid residues on erythrocytes. The study confirms that LTA binding is species-specific and influenced by erythrocyte type. These conclusions are based on the experimental data presented in the paper.